Introduction
Oral disease is a major public health problem all over the world and dental caries is the most common oral disease [15] . Microbiological assessments of caries-active sites and experimental animal studies have implicated S. mutans as the primary causative agent of human dental caries [17] . S. mutans can use multiple fermentable sugars, resulting in the production of acids. These acids cause dissolution of minerals in the tooth enamel, ultimately leading to dental caries. In addition to acid production, another virulence factor of S. mutans is its ability to form biofilms on the tooth surface, known as dental plaque. S. mutans persistently colonizes the tooth surface in the presence of dietary sugars and remains in the dental plaque, despite mechanical removal (tooth brushing) and general antiseptic efforts [7] .
In recent years, the wide-spectrum use of antibiotics has led to the emergence of drug-resistant strains [2] . Therefore, the development of new therapeutic methods to control bacterial infection is urgently needed. Antimicrobial peptides (AMPs) have come to the forefront as novel therapeutic agents owing to their killing activity against a wide spectrum of bacteria, including drug-resistant strains [5] .
Most AMPs have natural L-amino acid residues and are therefor subject to rapid proteolysis in vivo. The replacement of L-with D-amino acids makes little difference in activity, but creates enhanced resistance to enzymatic degradation and hence increases the overall activity of the AMPs [12] . Therefore, D-substituted AMPs offer an advantage over Lsubstituted AMPs and could be more suitable and potent active drug candidates [13] . According to recent studies, D-amino acids (such as D-leucine, D-methionine, D-tyrosine, and D-tryptophan) can prevent biofilm formation of Staphylococcus aureus, Pseudomonas aeruginosa, and Bacillus subtilis [6] .
In our previous studies, we designed and synthesized some AMPs, such as P-113, Pac-525, and D-Nal-Pac-525 [25, 26] . They are 9 to 12 amino acids peptides. P-113 is a Hisrich 12 amino acids fragment of saliva protein histatin 5, Ac-AKRHHGYKRKFH-NH 2 . Pac-525 is a tryptophan (Trp)-rich 9 amino acids peptide, Ac-KWRRWVRWI-NH 2 . D-NalPac-525 (MW 1,385.7 Da) is the Pac-525 analog with all trp residues replaced by D-β-naphthylalanine. D-Nal-Pac-525 exhibited improved antimicrobial activity toward E. coli, S. aureus, B. cereus, and P. aeruginosa [21] .
The aim of this study was to screen the most effective antimicrobial peptide from our three AMPs (P-113, PAC-525, D-Nal-Pac-525) on S. mutans, and test its activity on S. mutans growth and biofilm formation. Morphological and structural changes induced by the AMPs were examined by scanning electron microscopy (SEM) and transmission electron microscopy (TEM), respectively.
Materials and Methods

Bacterial Strain
S. mutans UA159 (ATCC700610) was used in this study. S. mutans UA159 was grown under anaerobic conditions in brain-heart infusion (BHI) medium at 37 o C.
Preparation of AMPs
AMPs (P-113, PAC-525, D-Nal-Pac-525) were synthesized using Multiple Peptide Systems, as described previously [21] . The purities (>95%) and authenticities of all peptides were determined by analytical reverse-phase high-pressure liquid chromatography (HPLC) and mass spectroscopy.
Antimicrobial Activity
The minimum inhibitory concentration (MIC) was determined by the standard broth microdilution method of the national committee for Clinical Laboratory Standards [3] . The assay was performed in a flat-bottom 96-well microtiter plate (Nunc 167008). Briefly, S. mutans was cultivated in BHI broth at 37 o C to early stationary phase and diluted to a final density of ~1×10
5 CFU/ml in BHI medium. AMPs was serially diluted in BHI medium and added to the culture of S. mutans. The final concentration of AMPs was 0.5, 1, 2, 4, 8, and 16 µg/ml, respectively. After incubation at 37 o C for 24 h, the optical density of the culture was measured at 600 nm (OD 600 ) using a microplate reader (Multiskan Ascent 354, Thermo Labsystems). The MIC was determined as the lowest concentration of compound that showed no visible growth (visual determination), which corresponds to OD 600 < 0.01 above the well containing only medium.
The growth inhibitory activity of D-Nal-Pac-525 against S. mutans was evaluated in more detail by following the OD 600 in time, as described previously with minor modification [9] . The D-Nal-Pac-525 solution was added into the overnight culture of S. mutans to give the final concentrations of 1, 2, and 4 µg/ml, respectively. Then the culture was incubated at 37 o C under anaerobic condition. The inhibitory effect was determined by plotting OD 600 against time.
The bactericidal activity of D-Nal-Pac-525 was determined using the broth dilution method by enumeration of viable organisms (CFU) [8] . D-Nal-Pac-525 was added to an overnight culture of S. mutans (~1×10 8 CFU/ml) to give the final concentrations of 2, 4, 8, and 16 µg/ml, respectively. The culture was incubated at 37 o C under anaerobic condition and samples were taken at 2 and 4 h. To determine the CFU, the samples were serially diluted (1:10) in BHI and subsequently spread on BHI plates. Plates were then incubated at 37 o C under anaerobic condition for 24 h, and colonies were counted to determine survivors.
Scanning Electron Microscopy
D-Nal-Pac-525 was added to the culture of S. mutans (~10 8 CFU/ml) to a final concentration of 4 µg/ml. After incubation at 37 o C under anaerobic conditions for 4 h, bacteria were harvested by centrifugation, washed twice with 0.1 M phosphate buffered saline (PBS pH 7.2) and fixed with 2.5% glutaraldehyde. Samples were dehydrated in a grade series of t-butyl alcohol solutions (70%, 80%, 90%, and 100%) and then frozen at -20 o C. The samples were dried under vacuum at 4 o C, and then coated with gold using an anion sputter (JFC-1100, JEOL). The morphology of the bacteria was observed using a scanning electron microscope (JSM-6510LV, JEOL) at an operating voltage of 20 kV.
Transmission Electron Microscopy
D-Nal-Pac-525 was added to a culture of S. mutans (~10 8 CFU/ml) to a final concentration of 4 µg/ml. After incubation at 37 o C under anaerobic conditions for 4 h, bacteria were harvested. The bacteria were fixed with 2.5% glutaraldehyde and then washed twice with 0.1 M PBS (pH 7.2). The samples were post-fixed with 1% OsO 4 for 1 h at room temperature and washed three times with 0.1 M PBS. The samples were dehydrated in a grade series of ethanol solutions (70%, 80%, 90%, and 100%) and embedded in Epon 812. Thin sections of the specimens were cut with a diamond knife using an ultramicrotome (EMUC6, Leica) and the sections were double stained with saturated uranyl acetate and lead citrate. Grids containing the stained sections were examined with a JEM-2000EX transmission electron microscope at an operating voltage of 120 kV.
Effect of D-Nal-Pac-525 on S. mutans Biofilm Formation
The biofilm assay was performed as described by Stepanovic et al. [18] , with slight modification. Biofilm formation was propagated in the wells of a sterile 96-well flexible vinyl (PVC) microplate (Costar 2595). D-Nal-Pac-525 was serially diluted and 200 µl was added to the wells to final concentrations of 0.25, 0.5, 1, 2, or 4 µg/ml, respectively. An overnight culture of S. mutans was diluted to a final density of ~1×10
5 CFU/ml with BHI broth supplemented with 3% sucrose, and 200 µl was added to each well. Untreated control wells contained only S. mutans and no DNal-Pac-525. Negative control wells contained only BHI broth. The plates were incubated under anaerobic conditions for 24 h at 37 o C, after which the medium was carefully removed and the wells were washed three times with sterile distilled water. The remaining attached bacteria were fixed with 250 µl of methanol per well for 15 min. The wells were emptied, air dried, and then stained with 250 µl of 0.01% crystal violet solution for 5 min at room temperature. The excess stain was rinsed off with distilled water and the wells were air dried. The dye bound by the biofilm was solubilized with 250 µl of 95% (v/v) ethanol per well. The absorbance at 600 nm of each well was measured by a microplate reader (Multiskan Ascent 354, Thermo Labsystems).
Statistical Analysis
Results were expressed as means and standard deviations (SD). Differences amongst groups were compared by analysis of variance, and the Student's t-test was used to calculate the significance of the difference between the different groups. A p value < 0.05 was considered significant.
Results
Inhibitory Effect on S. mutans Growth and MIC Measurement
The MIC values for the peptides (P-113, PAC-525, DNal-Pac-525) on S. mutans UA159 are shown in Table 1 .
D-Nal-Pac-525 inhibited the growth of S. mutans UA159 (Fig. 1) . D-Nal-Pac-525 at 4 µg/ml obviously inhibited the growth of S. mutans UA159 completely. Low inhibition was found in the presence of D-Nal-Pac-525 at lower concentration (2 µg/ml).
The bactericidal activity of D-Nal-Pac-525 against S. mutans is shown in a concentration-dependent manner (Fig. 2) . The cell numbers with the treatment of D-Nal-Pac-525 at 8 and 16 µg/ml were dramatically decreased compared with the untreated control.
SEM and TEM
SEM was used to observe morphological changes of the S. mutans treated with D-Nal-Pac-525. As shown in Fig. 3A , the untreated S. mutans had a smooth cell surface and exhibited a normal spherical shape. In contrast, the S. mutans treated with D-Nal-Pac-525 showed remarkable changes in cellular shape (Fig. 3B) . The S. mutans treated with D-Nal-Pac-525 lost the typical shape and showed elongated spheres, which appeared longer than untreated cells. S. mutans treated with D-Nal-Pac-525 exhibited a rough cell surface with discrete ridges. In addition to whole cells, cellular debris was observed in the images of S. mutans treated with D-Nal-Pac-525 (Fig. 3B ), but not in the controls. TEM was used to observe the effect of D-Nal-Pac-525 on S. mutans ultrastructure. In electron micrographs, the untreated S. mutans had an intact and apparent cell wall structure as an electron dense line (Figs. 4A, 4C, 4E ). The S. mutans treated with D-Nal-Pac-525 exhibited severe morphological defects. Upon treatment, the cytoplasmic membrane and cellwall became faint or even completely disrupted (Figs. 4B, 4D, 4F, 4G ). Electron-dense regions, absent in control cells, were observed in the D-Nal-Pac-525-treated cells (Fig. 4D) . TEM revealed that treatment with DNal-Pac-525 resulted in nucleoid segregation and loss of spatial organization in comparison with the untreated cells (Figs. 4B, 4D) . The S. mutans treated with D-Nal-Pac-525 showed cytoplasmic condensation (Fig. 4G) .
Inhibitory Activity Against S. mutans Biofilm Formation D-Nal-Pac-525 inhibited the growth of planktonic S. mutans; however, in the oral cavity, S. mutans is predominantly found in biofilms. D-Nal-Pac-525 prevented visual biofilm formation at 2 µg/ml and above (Fig. 5A) . Quantification of biofilm formation using CV staining confirmed that, with 2 and 4 µg/ml of D-Nal-Pac-525, biofilm formation was completely prevented, confirming the results of the visual observations (Figs. 5A , 5B).
Discussion
AMPs are promising novel therapeutic agents that could overcome the emerging problem of antibiotic resistance. The naturally derived AMPs are generally between 12 to 50 amino acids in length and are folded into several structural groups. However, there are some problem needed to be solved, such as how AMPs can work effective when they meet enzyme digestion and high salt in the natural environments. From our previous studies, we had found that D-Nal-Pac-525, replacing in Pac-525 the trp residues with β-naphthylalanine, showed improved antimicrobial activity and more salt resistance than their predecessors [21, 23] . In the oral cavity, some AMPs (e.g., KSL, MUC7) have been tested for antimicrobial activity against cariogenic S. mutans and its biofilm formation [10, 19] . Thus, we investigated the effect of D-Nal-Pac-525 on S. mutans growth and its biofilm formation.
In planktonic cultures, D-Nal-Pac-525 had bactericidal activity against S. mutans (Fig. 2) . The MIC of D-Nal-Pac-525 toward S. mutans was 4 µg/ml. It is comparable with those of other AMPs to S. mutans, including human defensins (~ 6 µM) and magainin (1 µg/ml) [1, 16] .
The majority of AMPs do not target specific molecular receptors of pathogens, but rather interact with and permeate microbial lipid membranes [24] . There are two common and functional requirements of AMPs: they are generally cationic, which facilitates their interaction with negatively charged microbial surfaces; and they have amphipathic structures that permit their incorporation into the microbial membrane. In a previous study, D-Nal-Pac-525 was found to bind to negatively charged phospholipid vesicles and induce dye leakage from the vesicles [21] . In the present study, SEM and TEM results indicate that the D-Nal-Pac-525 causes visible mophological and structural alterations. The cell wall and cytoplasmic membrane of S. mutans were disrupted and lost their integrity upon treatment with D-Nal-Pac-525 (Figs. 4B, 4D, 4F ). In addition, treated S. mutans were significantly longer than untreated cells (Fig. 4G) . From the data of growth curve (Fig. 1) , DNal-Pac-525(4 µg/ml) can inhibit the growth of S. mutans. The cell wall disruption may lead to a change in the osmotic pressure of S. mutans, resulting in S. mutans cells swelling, as in the target cell in Fig. 4G . Inhibition of peptidoglycan synthesis is an important mechanism of AMP action [22] . The integrity of the cytoplasmic membrane is integrally related to the biosynthesis of peptidoglycan, because peptidoglycan precursors are transported across the cytoplasmic membrane. The results of TEM confirmed that the cell wall of S. mutans treated with D-Nal-Pac-525 was disrupted and lost its integrity. The S. mutans treated with D-Nal-Pac-525 contains disorganized multiple chromosomal copies. Elbaz and BenYehua [4] reported that the integrity of the B. subtilis cell wall is necessary for synchronizing chromosome architecture with cell growth. The cells treated with D-Nal-Pac-525 lost cell membrane integrity and their nucleoids were detached from the cell wall, and then failed to properly package and segregate their DNA, resulting in the formation of large polyploid cells.
Dental caries is considered as a classic biofilm disease [20] . Oral bacteria are often associated with biofilm (dental plaque), forming highly organized microbial communities. Dental plaque is composed of a large numbers of bacterial species (>500 bacterial species) at a high cell density (~10 11 cells/g wet weight) [14] . The ability to form biofilm has been considered as one of the virulence factors for many oral pathogenic bacteria. In mature dental plaque, S. mutans is a regular member. However, in cariogenic biofilms, the number of S. mutans increases significantly [11] . Bacteria within a biofilm are invariably less susceptible to antibiotic treatment than their planktonic counterparts. The results of the present study indicate that D-Nal-Pac-525 at 2 µg/ml was able to inhibit the biofilm formation of S. mutans. However, D-Nal-Pac-525 could not destroy pre-existing biofilms (data not shown). The inhibition of D-Nal-Pac-525 on biofilm formation might be due to its inhibition on the growth of planktonic bacteria and bacterial colonization at the early stage of biofilm formation.
In conclusion, our results suggest that the AMP D-NalPac-525 has antibacterial activity against S. mutans and inhibits its biofilm. It suggests that D-Nal-Pac-525 is a potential candidate to prevent dental caries. However, in the oral cavity, S. mutans occurs in the dental plaque (biofilm), a complex ecosystem. The effects of D-Nal-Pac-525 on the growth and biofilm formation of other oral pathogenic species remain to be determined.
